Trial intelligence / Profile preview

Lianxia Xiaopi Capsule for Functional Dyspepsia (Phase II)

CTR20140016Phase 2Completed

Sponsor
Tasly New Resource Pharmaceutical
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Lianxia Xiaopi Granules in functional dyspepsia (FD), sponsored by Tasly New Resource Pharmaceutical. Started Mar 2014; status: completed.

02

Drugs

Lianxia Xiaopi Granules
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on CTR20140016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call